Sign up for Table of Contents Alerts.

Email this page

Print this page

Extra Views

Cancerous miRNAs and their regulation

Xu-Bao Shi, Clifford G. Tepper and Ralph W. deVere White

Purchase article for $19

Subscribe to this journal for $129/year

Although they account for only a very minor fraction of the expressed genome, microRNAs (miRNAs) are pivotal regulators of development and cellular homeostasis through their control of diverse cellular processes including proliferation, differentiation, apoptosis, survival, motility, and morphogenesis. Accordingly, several miRNAs have been functionally classified as proto-oncogenes or tumor suppressors and are aberrantly expressed in different cancer types. Deregulation (e.g., overexpression or loss of expression) of these so-called “cancerous” miRNAs can figure prominently in tumor initiation and progression by elaborating an inappropriate cellular program promoting uncontrolled proliferation, favoring survival, inhibiting differentiation, and/or promoting invasive behavior. These features would certainly promote tumor dissemination and persistence by favoring metastasis and therapy resistance. Cancerous miRNAs therefore represent attractive molecules for exploitation as biomarkers and therapeutic targets. In this review, we highlight recently characterized cancerous miRNAs and the mechanisms through which they contribute to the pathogenesis of human cancers. We also discuss the signal transduction pathways that regulate the expression of these miRNAs with particular attention to several essential transcription factors such as Myc, p53, and the androgen receptor.

Authors

Xu-Bao Shi

University of California at Davis School of Medicine; Sacramento, CA

Clifford G. Tepper

University of California at Davis School of Medicine; Sacramento, CA

Ralph W. deVere White

University of California at Davis School of Medicine; Sacramento, CA

Purchase article for $19

Subscribe to this journal for $129/year